Related Products of 1660-93-1, Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.1660-93-1, Name is 3,4,7,8-Tetramethyl-1,10-phenanthroline, molecular formula is C16H16N2. In a article，once mentioned of 1660-93-1
The series of complexes of formula [PtCl(eta2-olefin)(N^N)]+, previously investigated for N^N = N,N,N?,N?-tetramethyl-ethylenediamine (Me4en), has been extended to the case of aromatic diimines 1,10-phenanthroline (phen) and 3,4,7,8-tetramethyl-1,10-phenanthroline (Me4phen) and to a variety of olefins (ethene, propene and styrene). The complexes have been prepared by reaction of the [PtCl3(eta2-olefin)]? anions (K[PtCl3(eta2-styrene)] reported here for the first time) with N^N in basic methanol. The initial [PtCl{eta1-CH2?CH(R?)?OMe}(N^N)] (R? = Me, Ph) complexes are formed in quantitative yield and as pure Markovnikov isomer. The reaction of the alkoxylic species with non coordinating acids, results in the quantitative formation of the desired cationic pi-olefin complexes [PtCl(eta2-olefin)(N^N)]+. The phenanthroline ligand confers peculiar properties to the new compounds. In particular, by reaction with triethylamine, [PtCl{eta2-CH2[dbnd]CH(Me)}(N^N)]+ species, undergo deprotonation of the olefin and formation of the dimeric species [{PtCl(N^N)}2(mu-eta1:eta2-CH2CH[dbnd]CH2)]+ which could be isolated and characterized. Interestingly such product in acetonitrile gives a disproportionation with precipitation of [PtCl2(phen)] and formation in solution of the new eta3-allyl complex [Pt(eta3-C3H5)(phen)]ClO4.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1660-93-1, and how the biochemistry of the body works.Related Products of 1660-93-1
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI